AUSTRALIA Trends and Developments
Trends and Developments Contributed by: Suzy Madar, Matthew Swinn, Kate Hay and Scott Bouvier Mallesons Mallesons is recognised as one of the world’s most innovative top-tier international law firms, and offers a different perspective to commercial thinking and cli- ent experience. Effective 31 March 2026, the Austral- ian firm separated from the Chinese partnership, King & Wood and returned to “Mallesons”, a brand with an Australian history of more than 200 years. With more Band 1 practices, Band 1 and 2 ranked partners, and
overall ranked individuals than any other Australian firm, Mallesons is a unique, top-tier independent law firm in Australia. It takes a partnership approach in working with clients, focusing not just on what they want but how they want it. The firm always pushes the boundaries and shapes the legal market by chal- lenging clients to think differently about what a law firm can be. Kate Hay is partner in charge of Mallesons’ Melbourne office, with outstanding expertise in intellectual property across the life sciences and tech sectors. In addition to being a highly regarded patent litigator, Kate has acted on leading copyright and trade mark cases. Kate is a member of the Intellectual Property Committee of the Law Council of Australia, the Vice-President of the Australian Committee of the Intellectual Association for the Protection of Intellectual Property (AIPPI), the head of ChIP’s Victorian Chapter, and a member of the Intellectual Property Society of Australia and New Zealand (IPSANZ).
Authors
Suzy Madar leads Mallesons’ health and life sciences sector. With a background in biochemistry and genetics, she is a uniquely qualified specialist. Suzy is an accomplished patent litigation expert in highly
technical fields of medical science, as well as an expert in the regulation of therapeutic goods, including acting in disputes with the Therapeutic Goods Administration. She has unparalleled experience across the sector in biotechnology, pharmaceuticals, medical devices, and the application of existing regulations to new models of delivering health services. Suzy is a member of the Pharmaceutical and Biotechnology Subcommittee of the Intellectual Property Owners Association.
Scott Bouvier is widely recognised as one of Australia’s most prominent IP and technology lawyers. He has a highly regarded commercialisation
Matthew Swinn is highly recognised in the field in patent litigation, particularly in the life sciences sector. He also advises on therapeutic goods regulation, marketing and disputes. He serves as practice leader for
practice in life sciences, with particular focus on protecting investment in early- and late-stage research. He is a member of the Business Council of Australia’s Research Commercialisation Policy Working Group. He is the only lawyer mentor in the current Australian chapter of Creative Destruction Lab, a global objectives-based programme for massively scalable, seed-stage, science- and technology-based companies.
Mallesons’ Australia and Singapore dispute resolution teams, and is also a member of the national executive. Matthew is also active in law reform and harmonisation, including as former Chair of the Law Council of Australia’s IP Committee, liaison for the Federal Court of Australia’s IP Users’ Group and as Second Vice-President of the International Association for the Protection of Intellectual Property (AIPPI).
24 CHAMBERS.COM
Powered by FlippingBook